Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04380805
Title A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Akeso
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NZL | AUS


No variant requirements are available.